US Patent Issued to Gilead Sciences on Dec. 16 for "Tetracyclic compounds and methods for the treatment of Zika virus infection" (California Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,408, issued on Dec. 16, was assigned to Gilead Sciences Inc. (Foster City, Calif.).

"Tetracyclic compounds and methods for the treatment of Zika virus infection" was invented by Elbert Chin (San Mateo, Calif.), John O. Link (San Francisco), Ezra Roberts (San Francisco), James G. Taylor (Burlingame, Calif.) and Zheng-Yu Yang (Palo Alto, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds and methods for the treatment or prevention of Zika virus infection. For example, a compound of the formula(I):Wherein the variable substituents are described herein."

The patent was filed on May 19, 2022, under Application No. 17/748...